Advanced Medical Solutions Group plc (AIM:AMS)

Market Cap	465.31M +2.7%
Revenue (ttm)	228.94M +29.0%
Net Income	9.95M +40.3%
EPS	0.05 +39.1%
Shares Out	216.42M
PE Ratio	47.57
Forward PE	16.67
Dividend	0.03 (1.33%)
Ex-Dividend Date	May 28, 2026

Volume	892,595
Open	214.00
Previous Close	214.50
Day's Range	213.00 - 215.50
52-Week Range	187.00 - 272.00
Beta	0.71
Analysts	Strong Buy
Price Target	277.86 (+29.24%)
Earnings Date	Jun 16, 2026

About AIM:AMS

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, France, Europe, the United States, and internationally. It offers surgical products, such as tissue adhesives, sutures and clips, haemostats, biosurgical, internal fixation devices, infection control, and internal sealants under INTEGUSEAL, LiquiBand, RESORBA, LiquiBandFix8, and Seal-G, Vitalitec, and ActivHeal brand names. The company provid...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Employees: 1,800
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: AMS

Financial Performance

In 2025, AIM:AMS's revenue was 228.94 million, an increase of 28.96% compared to the previous year's 177.52 million. Earnings were 9.95 million, an increase of 40.32%.

Analyst Summary

According to 8 analysts, the average rating for AMS stock is "Strong Buy." The 12-month stock price target is 278p, which is an increase of 29.24% from the latest price.

Price Target

278p

(29.24% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 16, 2026

Data Sources Report a data error